J.‐L. Golmard

Diabetic foot ulcer and multidrug‐resistant organisms: risk factors and impact

Agnès Hartemann–Heurtier, J. Robert, Sophie Jacqueminet et al. · Diabetic Medicine · 2004 · 224 citations

Life Sciences, Infectious Diseases, Microbiology +17

Adapted Treatment of Epstein–Barr Virus Infection to Prevent Posttransplant Lymphoproliferative Disorder After Heart Transplantation

Sylvain Choquet, Shaïda Varnous, Claire Deback et al. · American Journal of Transplantation · 2014 · 77 citations · Full text

Medicine, Cardiology, Immunology +17

Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia

Nathalie Jacque, Stéphanie Nguyen, J.‐L. Golmard et al. · Bone Marrow Transplantation · 2014 · 55 citations

Medicine, Hematology, Molecular Biology +13

Vemurafenib pharmacokinetics and its correlation with efficacy and safety in outpatients with advanced BRAF-mutated melanoma

N. Kramkimel, Audrey Thomas‐Schoemann, Lilia Sakji et al. · Targeted Oncology · 2015 · 50 citations

Medicine, Oncology, Pharmacokinetics +11

Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors

Sophie Jacqueminet, Agnès Hartemann–Heurtier, R. Izzillo et al. · Diabetes & Metabolism · 2005 · 46 citations

Medicine, Cardiology, Surgery +14